Skip to content

Psychedelics

A Premium Partner In Psychedelics

KGK Science, as a small and agile Contract Research Organization (CRO), possesses the flexibility necessary to swiftly respond to the evolving landscape of innovative mental health therapies. This adaptability enables KGK to create top-tier testing environments tailored to emerging treatment options.

Within KGK’s own state-of-the-art facilities, we conduct phase I and II psychedelic-assisted therapy studies, alongside comprehensive mood and cognition research spanning diverse innovative and holistic treatments. KGK proudly holds a Controlled Substances Dealers license which allows the company to possess, sell/distribute, transport, import/export many of the commonly studied psychedelic drugs. (see list of inclusions on the side)

KGK’s goal is to foster global confidence in revolutionary mental health care, addressing a range of patient symptoms related to overall health and mental wellness. Through meticulous optimization of every research stage and the cultivation of a team of seasoned experts, KGK is committed to advancing the credibility and effectiveness of alternative healthcare approaches worldwide.

  • All studies conducted to pharmaceutical standards
  • Full recruitment support services available
  • KGK proudly holds a Controlled Substances Dealers license which allows the company to possess, sell/distribute, transport, import/export many of the commonly studied psychedelic drugs, including:
  • Psilocybin/psilocin
  • Ketamine
  • Salvinorin A
  • LSD
  • MDMA
  • Harmaline
  • DMT
  • Mescaline
  • Harmalol

The Science Behind Success

From clinical study design to impactful product marketing, KGK has client success down to a science. As a full-service premium contract research organization (CRO), KGK Science is one of the most reliable resources for brands looking for an experienced, trustworthy team of scientific researchers, consultants, and regulatory specialists to develop customized claim substantiation and path-to-market strategies.

Leading Clinical Research Since 1997

  • 400

    Clinical Trials in 40+ Indications

  • 150+

    Publications

  • 4000+

    Regulatory Projects Completed

  • 27

    Years In Business

  • 45,000

    Participant Database

Supporting Your Business with High-Quality Expertise

As a premium full-service contract research organization, KGK Science provides clinical trial research and regulatory services that meet the highest quality standards, customized to meet the needs of our clients. Contact us today and stake your claim.

google-site-verification=ODzIjcIVmduDgyhTx98JdCy2M5Br0YEsotjjaj0hZbI